Intellia Therapeutics Inc.

In News

Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates - Intellia Therapeutics

Intellia Therapeutics - Aug 06, 2026

Intellia Therapeutics Inc (NTLA) (Q2 2026) Earnings Call Highlights: Advancing LONVOSI Toward ... - Yahoo Finance

Yahoo Finance - Aug 06, 2026

[10-Q] Intellia Therapeutics, Inc. Quarterly Earnings Report - Stock Titan

Stock Titan - Aug 06, 2026

Intellia Therapeutics Q2 Earnings Call Highlights - TradingView

TradingView - Aug 07, 2026

Why Is NTLA Stock Jumping 5% Premarket Today? - Stocktwits

Stocktwits - Aug 08, 2026

Intellia Therapeutics Inc earnings matched, revenue fell short of estimates - Investing.com

Investing.com - Aug 06, 2026

Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema - Intellia Therapeutics

Intellia Therapeutics - Apr 27, 2026

INTELLIA THERAPEUTICS, INC. reports results for the quarter ended June 30 - Earnings Summary - TradingView

TradingView - Aug 06, 2026

State Street (NTLA) stake: 9.23M Intellia Therapeutics shares in 13G filing - Stock Titan

Stock Titan - Aug 07, 2026

Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Yahoo Finance - Aug 06, 2026

Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing - Intellia Therapeutics

Intellia Therapeutics - Apr 27, 2026

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates - Intellia Therapeutics

Intellia Therapeutics - Feb 26, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment